Two Sigma Investments’s Bluejay Diagnostics BJDX Stock Holding History

Two Sigma Investments’s Portfolio BJDX Stock Details BJDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-55	Closed	-$1.4K	–	3221
2024 Q3	$1.4K	Buy	+55	New	+$3.94K	﹤0.01%	3080

Other funds holding BJDX

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments's BJDX Position: Q4 2024 in Review

Two Sigma Investments sold out of Bluejay Diagnostics (BJDX) in Q4 2024, closing a stake of 55 shares — an estimated $1.4K sold.

Two Sigma Investments first reported a position in BJDX in Q3 2024 and held it in 1 quarter. The position peaked at $1.4K in Q3 2024. 3 funds tracked by Wall St. Rank hold BJDX as of Q4 2024.

Two Sigma Investments reported no remaining Bluejay Diagnostics position as of Q4 2024 after selling out during the quarter.
Two Sigma Investments sold 55 Bluejay Diagnostics shares in Q4 2024, an estimated $1.4K.
Two Sigma Investments first reported a position in Bluejay Diagnostics in Q3 2024 and held it in 1 quarter.
Two Sigma Investments's Bluejay Diagnostics position peaked at $1.4K in Q3 2024.
3 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.